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Potential antidiabetic and antioxidant activities of a heliangolide 
sesquiterpene lactone isolated from Helianthus annuus L. leaves
Heliangolide is a naturally occurring sesquiterpene lactone 
and its derivatives are biologically active compounds pres-
ent in most medicinal plants. This study evaluated the 
antioxidant and antidiabetic properties of a heliangolide 
sesquiterpene lactone isolated from Helianthus annuus L. 
leaves. The heliangolide sesquiterpene lactone was isolated 
through a combination of solvent-solvent partitioning, 
column chromatography, thin layer chromatography and 
high-performance liquid chromatography techniques. The 
antioxidant activity of the compound was evaluated using 
2,2-diphenyl-1-picrylhydrazyl (DPPH) and nitric oxide 
radical scavenging assays while the antidiabetic effects 
were investigated in alloxan-induced diabetic rats. The he-
liangolide derivative at the concentration of 954.2 µmol L–1 
showed 23.7 % DPPH and 26 % nitric oxide radical inhibi-
tions compared with 96.6 and 50.9 %, resp., displayed by the 
controls (2,271.2 µmol L–1). It also reduced the fasting blood 
glucose (FBG) levels in a time-dependent manner. The 
highest activity was recorded within 6 h post-treatment at 
0.2 mmol kg–1 bm. The heliangolide derivative exhibited 
significant (p < 0.05) antioxidant and antidiabetic proper-
ties and provides a basis for further development of con-
stituents of Helianthus annuus leaves for the management of 
such diseases.
Keywords: Helianthus annuus, heliangolide derivative, anti-
diabetic, antioxidant
Diabetes mellitus is a chronic metabolic disease that is caused by partial or complete 
insulin deficiency and/or insulin resistance (1). It is usually accompanied by renal failure, 
coronary artery disease, blurred vision, neuropathy and impaired wound healing that 
may predispose to limb amputation (1). These diabetes complications are attributed to 
hyperglycemia, hyperlipidemia and oxidative stress which often characterize diabetes 
mellitus (2). Type 2 diabetes is the most common form of diabetes and constitutes about 90 
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% of diabetes cases. It is clinically managed by chemotherapy with hypoglycemic drugs 
such as biguanides, sulphonylurea, amylin mimetics, alpha-glucosidase inhibitors, gli-
tazones and meglitinides (3). These antidiabetic drugs, despite being expensive and not 
readily available, have adverse side-effects that have significantly reduced their clinical 
usage.
As a result, the search for new hypoglycemic drugs with reduced side-effects is ongo-
ing in many laboratories worldwide (4). Several medicinal plants-derived bioactive com-
pounds have shown interesting potential against type 2 diabetes (5). Heliangolide, a 
known sesquiterpene lactone, is a bioactive secondary metabolite of medicinal plants with 
diverse pharmacological activities (6). It was first isolated as a constituent of Saussurea 
lappa root (7) and also in association with other sequiterpene lactones in many other plants, 
especially those belonging to the family Asteraceae (8, 9). Other isolated derivatives of ses-
quiterpene lactones are dihydrocostunolide, dehydrocostulactone, isodihydrocostunolide, 
β-cyclocostunolide, 9β-acetoxycostunolide and several 13-amino derivatives (10–12). Some 
of their activities include antidiabetic, antioxidant, antiinflammatory, hypolipidemic, 
anticancer and antifungal properties (13, 14).
H. annuus Linn. (family Asteraceae) is relevant in ethnopharmacology as a diuretic, 
antidiabetic, expectorant, gastrointestinal stimulant, antimicrobial agent, analgesic agent, 
etc. (15, 16). Antidiabetic activity of the crude methanolic extract of H. annuus has been re-
ported by Onoja and Anaga (17) but the bioactive antidiabetic principle is yet to be identi-




Methanol, HPLC grade, was obtained from Fischer Chemicals (UK). n-hexane, chlo-
roform, n-butanol, p-anisaldehyde, sulfuric acid, ethyl acetate, N-alpha-naphthyl-ethylene-
diamine, phosphoric acid, sulfanilic acid, sodium nitroprusside, silica gel and d-chloro-
form, 99.8 % D and 2,2-diphenyl-1-picrylhydrazyl were procured from Merck KGaA 
(Germany), Millipore water for UHPLC/+ESI-QqTOFMS/MS measurement was LC-MS 
grade (HiPerSolv CHROMANORM, VWR International, Belgium) and glibenclamide 
(GNC, Nigeria). Unless otherwise stated, all the reagents were used without purification.
Plant collection and extract preparation
The leaves of H. annuus were collected in June 2016 from the wild in Nsukka, Enugu 
state, Nigeria, and authenticated by a plant taxonomist in the Department of Plant Science 
and Biotechnology, University of Nigeria, Nsukka. It was deposited in the departmental 
herbarium with voucher number, UNN/VPP/2012/2. The leaves were dried under a shed at 
ambient temperature (25–27 °C). The extract of H. annuus was prepared using the cold 
maceration method in 80 % hydromethanol as described by Onoja and Anaga (17) and was 
referred to as hydromethanolic extract of H. annuus leaves (HEHAL).
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Solvent-solvent separation of HEHAL
The HEHAL was subject to solvent-solvent partitioning (10 g in 100 mL of 80 % aque-
ous methanol) with n-hexane, chloroform, ethyl acetate and n-butanol using a separating 
funnel as described by Bibi et al. (18) (Fig. 1).
Column chromatographic separation of n-butanol fraction
The n-butanol insoluble portion (2.8 g) formed on evaporation to dryness was dis-
solved in the mobile phase (ethyl acetate/methanol, 9:1) and introduced to the silica gel 60 
(0.06–0.20 mm particles) slurry packed column, 90 × 8 cm (GE Healthcare Europe GmbH, 
Germany), extract/silica gel ratio, 1:70, at room temperature. The fraction was eluted with 
a gradient of mobile phase consisting of ethyl acetate and methanol starting with 90 % 
ethyl acetate and gradually increasing the ratio of methanol up to 50 % at a flow rate of 0.5 
mL min–1.
Thin layer chromatographic analysis of fractions
Analytical TLC was performed on pre-coated silica gel 60 F254 plates, 20 × 10 cm (Merck 
KGaA GmbH, Germany) with various solvent systems consisting of ethyl acetate and 
methanol in appropriate ratios optimized for each experimental run at room temperature. 
The plates, developed over 8 cm distance, were visualized under UV light at 254/365 nm 
and sprayed with anisaldehyde-sulphuric acid detecting reagent. The collected eluates 
(20–25 mL) from the column chromatographic separation of n-butanol fraction were 
Fig. 1. Fractionation scheme of HEHAL (18).
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analysed by TLC at predetermined intervals and subsequently pooled into six sub-frac-
tions (tubes 37–189) based on their TLC profiles as follows: sub-fraction 1, 380 mg (tubes 
37–56), sub-fraction 2, 850 mg (tubes 59–98), sub-fraction 3, 508 mg (tubes 100–128), sub-
fraction 4, 330 mg (tubes 131–147), sub-fraction 5, 105 mg (tubes 152–177) and sub-fraction 
6, 120 mg (tubes 178–189).
Preparative HPLC isolation of compounds
Sub-fraction 2 (850 mg), obtained from the column chromatographic separation, was 
further separated and purified by preparative HPLC to yield a 76 mg of pure compound 
representing the dominant constituent of the most active sub-fraction. Isolation of the 
compound was done using the preparative HPLC system (Jasco, Germany, pump PU-2087 
plus, diode array detector MD 2018 plus, a column thermostat CO 2060 plus, autosampler 
AS 2055 plus, LC Net II ADC Chromatography Data Solutions). Separations were per-
formed on a reverse phase column Reprosil 100 C-18 (250 × 20 mm, 5 µm) using the binary 
gradient of the mobile phase (water and methanol) at a flow rate of 10 mL min–1 and col-
umn temperature of 40 ˚C with the sample injection loop of 1000 µL. The mobile phase 
Fig. 2. Preparative HPLC chromatograms of: a) CC sub-fraction 2, b) isolated heliangolide derivative, 
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optimized for the preparative HPLC consisted of water and methanol in gradient condi-
tions as follows: 60–30 % of water (10 min), 30–20 % water (5 min), 20–10 % water (5 min), 
10–0 % water (10 min) and 0 % water (10 min) and additional 5 minutes to return the system 
to the initial mobile phase. The retention time (tR) of the isolated compound under these 
conditions was 19.273 min as shown in Fig. 2.
Structural characterization of the isolated compound
1D-NMR spectra, proton (1H) and carbon-13 (13C) and 2D-NMR proton-proton correla-
tion spectroscopy (1H/1H COSY), proton-carbon-13 heteronuclear single quantum correla-
tion (1H/13C HSQC), and proton-carbon-13 heteronuclear multiple bond correlation (1H/13C 
HMBC) were recorded on the Agilent DD2 600 MHz spectrometer (Agilent Technologies, 
USA) at 25 °C. Samples were dried overnight in a desiccant-filled Desaga drying apparatus 
(Desaga, Germany). Solutions of the samples were typically prepared in deuterated chlo-
roform (CDCl3). The recorded spectra were referenced to the solvent signals of 1H 7.260 
ppm and 13C 77.000 ppm (CDCl3) and processed with MestRENOVA v. 11 (Mestrelab Re-
search, Chemistry Software Solutions, USA) software.
1H NMR data are reported indicating the chemical shift (d) in ppm, the integer (in 
cases where signals represent more than one proton, e.g., 2H or 3H), the multiplicity (s, 
singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad; dd, doublet of doublets, etc.) 
and the coupling constant(s) (J) in Hz. 13C NMR data are reported indicating only the 
chemical shifts (d, ppm). All the spectra data were compared with the library data.
Antioxidant activity
The heliangolide derivative in the concentration range 59.6–954.2 µmol L–1 was used 
in the following tests. Tests were performed in triplicate and ascorbic acid (142.0–2,271.2 
µmol L–1) was used as positive control. 
2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay. – The DPPH (Sigma Al-
drich, USA) scavenging property of the compound was evaluated as modified by Onoja et 
al. (19). DPPH is a stable violet coloured free radical that has the capacity to react with a 
hydrogen donor to form a stable yellow diamagnetic compound at room temperature 
within 30 minutes.
Nitric oxide radical inhibition activity. – The Griess reaction method as described by 
Marcocci et al. (20) was used to evaluate the nitric oxide radical inhibition activity of the 
heliangolide derivative. The protocol is hinged on the principle that in an aqueous medium 
and under physiological pH, sodium nitroprusside generates nitric oxide which can be 
estimated indirectly with Griess reagent.
Experimental animals
Eighteen 10-weeks old male albino Wistar rats (110–120 g) were used for the study. 
They were housed in aluminum cages in a well-ventilated room at ambient temperature 
(25–27 °C) and natural light/darkness cycle. The rats were acclimatized for 2 weeks and the 
experimental procedures were approved by the University of Nigeria Nsukka, Animal 
Ethical Committee.
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Antidiabetic activity
Diabetes was induced in 18 albino Wistar rats with alloxan (160 mg kg–1 bm) as de-
scribed by Sebai et al. (21). The diabetic rats were randomly assigned to 3 groups (n = 6) and 
received 5 % Tween-20 (5 mL kg–1 bm), glibenclamide (4 µmol kg–1 bm) and heliangolide 
derivative (0.2 mmol kg–1 bm), resp. All compounds were administered orally. The fasting 
blood glucose (FBG) was determined after 1, 3, 6 and 24 h in the blood collected from the 
tail vein.
Statistical analysis
Data obtained presented as mean ± SEM was analysed using one-way analysis of vari-
ance (ANOVA) and post-hoc comparisons were carried out using Dunnett’s test in SPSS 
version 20. Differences at p < 0.05 were considered significant.
RESULTS AND DISCUSSION
Characterization of heliangolide
The heliangolide sesquiterpene lactone was isolated from a column sub-fraction 2 
using preparative HPLC as a white crystalline compound. The 13C/1H HSQC spectra (Table 
I) revealed a C22 compound comprised of 3 CH3 (methyl), 4 CH2 (methylene), 8 CH (me-
thine) and 7 Cq (quaternary carbons) with the elemental formula of C22H26O8 deduced 
Fig. 3. UHPLC/+ESI-QqTOF-MS/MS of heliangolide derivative (0.1 mg mL–1). a) Upper panel indicates 
a base peak MS chromatogram, m/z 50–1000; b) lower panel shows a base peak UV chromatogram in 
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from the +ESI–QqTOF mass spectrum (Fig. 3). The 1H signals at δ 1.82–1.79 ppm were due 
to the methyl protons attached to the cyclodecene ring, whereas the methyl proton of me-
thoxylate ion was assigned to a singlet at δ 2.09 ppm. The signal at δ 6.36–6.37 ppm was 
attributed to the furan protons, whereas the methylene proton (=CH2) and the hydroxyl 
proton (-OH) attached to the furan were assigned to δ 5.78 (d, J = 12.2 Hz) and δ 6.60 ppm 
(d, J = 7.5 Hz) resp. (Table I). A characteristic downfield signal at δ 5.76 ppm, br doublet, 





1H (δ, ppm), 
mult., J (Hz)
13C / 1H 
HSQC
13C/ 1H HMBC 1H/1H COSY
1 103.5 6.14, 1H, br s, -CH- – H-5‘
2 29.6
2.28, 1H, m
-CH2- C-5, C-10 H-3, H-5, H-82.70, 1H, m
3 79.4 5.26, 1H, br d, 11 -CH- – H-9
4 137.2 – -C- – –
5 126.3 5.17, 1H, br d, 6.5 -CH- C-15, C-7, C-3 H-6, H-9, H-2
6 75.6 5.86, 1H, m -CH- – H-5
7 48.5 2.95, 1H, br s -CH- C-13, C-5, C-11, C-12 H-5
8 79.3 5.24, 1H, dd, 2.3, 7.0 -CH- C-5 H-9
9 43.6
2.45, 1H, m
-CH2- C-10, C-5 H-82.72, 1H, br d, 2.1
10 135.2 – -C- – –
11 137.2 – -C- – –
12 169.6 – -C- – –
13 125.2
5.78, 1H, d, 12.2
-CH2- C-7, C-8, C-12, C-11 H-76.36, 1H, d, 12.3
14 19.6 1.79, 3H, br s -CH3 C-9 –
15 23.2 1.82, 3H, br s -CH3 C-3, C-5, C-4 –
1‘ 161.2 – -C- – –
2‘ 137.4 6.60, 1H, d, 7.1 -CH- C-5‘, C-1‘ H-5‘
3‘ 137.3 6.60, 1H, d, 7.5 -CH- C-5‘, C-1‘ H-5‘
5‘ 72.5
4.65, 1H, s
-CH2- C-1, C-1‘, C-2‘ H-2‘, H-1, 4.82, 1H, s
1‘‘ 169.9 – -C- –
2‘‘ 21.4 2.09, 3H, s -CH3 C-3, C-1‘‘ –
3‘‘ 169.5 – -C- –
All measurements were done in deuterated chloroform, CDCl3, at 600 MHz (1H) and 150 MHz (13C).
COSY – proton-proton correlation spectroscopy, HMBC – carbon-proton heteronuclear multiple bond correlation, 
HSQC – carbon-proton heteronuclear single quantum correlation
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suggests a shielded proton signal by the -OCOMe group. The large coupling constant of 
H-3 (J = 11 Hz) is an indication of a diaxial spin-spin coupling with the axial position for 
H-3 on the a-face and an equatorial β-orientation for the OCOMe group. The 13C NMR 
signals at δ 137.18–137.44 ppm were attributed to furan carbons, δ 169.59–169.90 ppm to 
carbonyl carbons (Table I). The 1H/1H COSY spectrum showed the intense correlation of 
proton signals at δ 5.25 and 2.45 ppm for H-8 and H-9, resp., in addition to a weak correla-
tion of H-7, δ 2.95 and H-5, δ 5.17 ppm. However, the two proton signal at δ 6.60, H-2’/H-3’ 
showed significant correlation with the signal at δ 4.65, H-5’ (Table I).
All the spectral evidence was in full agreement with the structure of a heliangolide 
lactone as shown in Fig. 3 and further confirmed with literature values of 20-dehydroeu-
cannabinolide previously isolated from Disynnaphia multicrenulata (22). Interestingly, this 
is the first time this heliangolide derivative is to be reported in Helianthus annuus (Fig. 4). 
Sesquiterpene lactones are generally soluble in non-polar solvents, but the solubility of this 
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Fig. 4. Chemical structure of the isolated heliangolide derivative (20-dehydroeucannabinolide); 
(UHPLC/+ESI-QqTOF MS: tR 2.665 min, MS (m/z): 419.1687 [M+H]+; calculated for C22H27O8+: 419.4458; 
UV λmax= 220 nm. 
Fig. 5. DPPH radical scavenging activities of the heliangolide derivative. Data are expressed as mean 
± SEM, n = 3.
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Antioxidant activity of the heliangolide derivative
Our preliminary results showed that the isolated compound had produced concentra-
tion-dependent inhibition of free radicals. At 954.2 µmol L–1, it showed 23.7 % DPPH (Fig. 
5) and 26.0 % nitric oxide (Fig. 6) radical inhibition compared with 96.6 and 50.9 %, resp., 
caused by ascorbic acid at 2,271.2 µmol L–1. The IC50 estimate of heliangolide against DPPH 
and nitric oxide radical is much higher than 950 µmol L–1 (expectedly >3 mmol L–1), while 
the IC50 of ascorbic acid against DPPH and nitric oxide radical is much lower than 140 µmol 
L–1 and around 2 mmol L–1, resp. The isolated compound might exhibit free radical scav-
enging effects similar to the report of Eliza et al. (14), still markedly lower than that of 
ascorbic acid. All of this suggests that it can possibly mitigate the pathogenesis and com-
plications of diabetes mellitus.
Antidiabetic activity of the heliangolide derivative
The heliangolide derivative (200 mmol kg–1) reduced the fasting blood glucose (FBG) 
level in a time-dependent manner. Statistically significant difference vs. control group (p < 
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Fig. 6. Nitric oxide scavenging activities of heliangolide derivative. Data are expressed as mean ± 
SEM, n = 3.
Fig. 7. Antidiabetic activities of the heliangolide derivative. Data are expressed as mean ± SEM, n = 6. 
Significant difference relative to 5 % Tween-20 treated group: *p < 0.05; FBS – fasting blood sugar level.
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0.05) was achieved already after an hour and maximum effect was obtained within 6 h 
post-treatment (Fig. 7), which made it comparable to that of glibenclamide (4 mmol kg–1).
This suggests that the compound might have reduced glucose absorption, increased 
glucose uptake by the liver and skeletal muscle and/or stimulated insulin release. An ele-
vated level of tissue glycogen has been reported in sesquiterpene lactones-treated dia-
betic rats (24). Sesquiterpene lactones stimulate beta-cell regeneration and insulin produc-
tion through the impaired expression of nitric oxide synthase (25). The promising 
scavenging of nitric oxide radical by the heliangolide derivative goes along this assump-
tion.
The exo-methylene group on the lactone part of sesquiterpenes is required for cyto-
toxicity (26). This may imply that the derivative isolated in this study, having the intact 
exo-methylene group and promising antioxidant activity, could possess anticancer proper-
ties as well (9). The early and high percentage of FBS level reduction observed within 3 h 
(53.0 %) reaching maximum at 6 h (68.5 %) and declining at 24 h (35.4 %) was also signifi-
cant in the heliangolide-treated group. This effect, like in the majority of antidiabetic 
chemotherapy, could require regular maintenance doses to keep the blood plasma levels 
within its therapeutic window. However, the antidiabetic activity of the tested helian-
golide derivative was much lower than that of the reference drug, glibenclamide.
CONCLUSIONS
A heliangolide sesquiterpene lactone (20-dehydroeucannabinolide) was isolated from 
Helianthus annuus leaves for the first time. It exhibited promising antioxidant and antidia-
betic activities and, therefore, the isolated compound might serve as the starting point in 
the development of new compounds against diabetes and diseases associated with ROS.
Acronyms, abbreviations, symbols. – FBG – fasting blood glucose, COSY – proton-proton correla-
tion spectroscopy, DPPH – 2,2-diphenyl-1-picrylhydrazyl, GLB – glibenclamide, HMBC – carbon-
proton heteronuclear multiple bond correlation, HSQC – carbon-proton heteronuclear single quan-
tum correlation.
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